Form 4: Cardlytics Director Andre J. Fernandez Acquires 11,000 Restricted Stock Units
SEC Form 4 Filing
Director Andre J. Fernandez acquired 11,000 restricted stock units in Cardlytics, Inc. on May 23, 2024.
Summary
- On May 23, 2024, Andre J. Fernandez, a director of Cardlytics, Inc., acquired 11,000 restricted stock units (RSUs).
- Each RSU represents a contingent right to receive one share of Cardlytics common stock or its cash equivalent, at the Issuer's election.
- The RSUs will vest in full on the one-year anniversary of the grant date, provided Fernandez remains a director on that date.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing a stock transaction. It doesn't inherently convey positive or negative sentiment.
Future Outlook
The RSUs will vest in full on the one-year anniversary of the grant date, provided that the Reporting Person remains a director of the Issuer on such vesting date.
Industry Context
Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.
Stakeholder Impact
- The acquisition of RSUs by a director can be seen as a positive sign, aligning the director's interests with those of the shareholders.
Key Dates
| Date | Description |
|---|---|
| 05/23/2024 | Date of transaction: Andre J. Fernandez acquired 11,000 restricted stock units. |
| One-year anniversary of 05/23/2024 | Vesting date for the 11,000 RSUs, contingent on continued service as a director. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.